Literature DB >> 24336827

Utility of (1-3)-β-D-glucan testing for diagnostics and monitoring response to treatment during the multistate outbreak of fungal meningitis and other infections.

Anastasia P Litvintseva1, Mark D Lindsley, Lalitha Gade, Rachel Smith, Tom Chiller, Jennifer L Lyons, Kiran T Thakur, Sean X Zhang, Dale E Grgurich, Thomas M Kerkering, Mary E Brandt, Benjamin J Park.   

Abstract

BACKGROUND: The 2012 outbreak of fungal meningitis associated with contaminated methylprednisolone produced by a compounding pharmacy has resulted in >750 infections. An important question facing patients and clinicians is the duration of antifungal therapy. We evaluated (1-3)-β-d-glucan (BDG) as a marker for monitoring response to treatment.
METHODS: We determined sensitivity and specificity of BDG testing using the Fungitell assay, by testing 41 cerebrospinal fluid (CSF) specimens from confirmed cases of fungal meningitis and 66 negative control CSF specimens. We also assessed whether BDG levels correlate with clinical status by using incident samples from 108 case patients with meningitis and 20 patients with serially collected CSF.
RESULTS: A cutoff value of 138 pg/mL provided 100% sensitivity and 98% specificity for diagnosis of fungal meningitis in this outbreak. Patients with serially collected CSF were divided into 2 groups: those in whom BDG levels declined with treatment and those in whom BDG remained elevated. Whereas most patients with a decline in CSF BDG had clinical improvement, all 3 patients with continually elevated BDG had poor clinical outcomes (stroke, meningitis relapse, or development of new disease).
CONCLUSIONS: Our data suggest that measuring BDG in CSF is a highly sensitive test for diagnosis of fungal meningitis in this outbreak. Analysis of BDG levels in serially collected CSF demonstrated that BDG may correlate with clinical response. Routine measurement of BDG in CSF may provide useful adjunctive data for the clinical management of patients with outbreak-associated meningitis.

Entities:  

Keywords:  (1-3)-β-d-glucan; Exserohilum; Fungitell; fungal meningitis

Mesh:

Substances:

Year:  2013        PMID: 24336827      PMCID: PMC4047277          DOI: 10.1093/cid/cit808

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  21 in total

1.  The (1,3){beta}-D-glucan test as an aid to early diagnosis of invasive fungal infections following lung transplantation.

Authors:  Barbara D Alexander; P Brian Smith; R Duane Davis; John R Perfect; L Barth Reller
Journal:  J Clin Microbiol       Date:  2010-08-18       Impact factor: 5.948

Review 2.  Immune recognition of fungal beta-glucans.

Authors:  Gordon D Brown; Siamon Gordon
Journal:  Cell Microbiol       Date:  2005-04       Impact factor: 3.715

Review 3.  Human Exserohilum and Bipolaris infections: report of Exserohilum nasal infection in a neutropenic patient with acute leukemia and review of the literature.

Authors:  D Douer; A Goldschmied-Reouven; S Segev; I Ben-Bassat
Journal:  J Med Vet Mycol       Date:  1987-08

4.  Diagnostic value of DNA, (1-3)-beta-d-glucan, and galactomannan detection in serum and bronchoalveolar lavage of mice experimentally infected with Aspergillus terreus.

Authors:  Suhail Ahmad; Ziauddin U Khan; Ajmal Muliyam Theyyathel
Journal:  Diagn Microbiol Infect Dis       Date:  2007-06-15       Impact factor: 2.803

Review 5.  beta-Glucans and dectin-1.

Authors:  S Vicky Tsoni; Gordon D Brown
Journal:  Ann N Y Acad Sci       Date:  2008-11       Impact factor: 5.691

6.  Fungal infections associated with contaminated methylprednisolone injections.

Authors:  Rachel M Smith; Melissa K Schaefer; Marion A Kainer; Matthew Wise; Jennie Finks; Joan Duwve; Elizabeth Fontaine; Alvina Chu; Barbara Carothers; Amy Reilly; Jay Fiedler; Andrew D Wiese; Christine Feaster; Lex Gibson; Stephanie Griese; Anne Purfield; Angela A Cleveland; Kaitlin Benedict; Julie R Harris; Mary E Brandt; Dianna Blau; John Jernigan; J Todd Weber; Benjamin J Park
Journal:  N Engl J Med       Date:  2012-12-19       Impact factor: 91.245

7.  Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome.

Authors:  Zekaver Odabasi; Gloria Mattiuzzi; Elihu Estey; Hagop Kantarjian; Fumihiro Saeki; Richard J Ridge; Paul A Ketchum; Malcolm A Finkelman; John H Rex; Luis Ostrosky-Zeichner
Journal:  Clin Infect Dis       Date:  2004-06-28       Impact factor: 9.079

8.  Cerebrospinal fluid and plasma (1-->3)-beta-D-glucan as surrogate markers for detection and monitoring of therapeutic response in experimental hematogenous Candida meningoencephalitis.

Authors:  Ruta Petraitiene; Vidmantas Petraitis; William W Hope; Diana Mickiene; Amy M Kelaher; Heidi A Murray; Christine Mya-San; Johanna E Hughes; Margaret P Cotton; John Bacher; Thomas J Walsh
Journal:  Antimicrob Agents Chemother       Date:  2008-09-08       Impact factor: 5.191

9.  The sequence of the human genome.

Authors:  J C Venter; M D Adams; E W Myers; P W Li; R J Mural; G G Sutton; H O Smith; M Yandell; C A Evans; R A Holt; J D Gocayne; P Amanatides; R M Ballew; D H Huson; J R Wortman; Q Zhang; C D Kodira; X H Zheng; L Chen; M Skupski; G Subramanian; P D Thomas; J Zhang; G L Gabor Miklos; C Nelson; S Broder; A G Clark; J Nadeau; V A McKusick; N Zinder; A J Levine; R J Roberts; M Simon; C Slayman; M Hunkapiller; R Bolanos; A Delcher; I Dew; D Fasulo; M Flanigan; L Florea; A Halpern; S Hannenhalli; S Kravitz; S Levy; C Mobarry; K Reinert; K Remington; J Abu-Threideh; E Beasley; K Biddick; V Bonazzi; R Brandon; M Cargill; I Chandramouliswaran; R Charlab; K Chaturvedi; Z Deng; V Di Francesco; P Dunn; K Eilbeck; C Evangelista; A E Gabrielian; W Gan; W Ge; F Gong; Z Gu; P Guan; T J Heiman; M E Higgins; R R Ji; Z Ke; K A Ketchum; Z Lai; Y Lei; Z Li; J Li; Y Liang; X Lin; F Lu; G V Merkulov; N Milshina; H M Moore; A K Naik; V A Narayan; B Neelam; D Nusskern; D B Rusch; S Salzberg; W Shao; B Shue; J Sun; Z Wang; A Wang; X Wang; J Wang; M Wei; R Wides; C Xiao; C Yan; A Yao; J Ye; M Zhan; W Zhang; H Zhang; Q Zhao; L Zheng; F Zhong; W Zhong; S Zhu; S Zhao; D Gilbert; S Baumhueter; G Spier; C Carter; A Cravchik; T Woodage; F Ali; H An; A Awe; D Baldwin; H Baden; M Barnstead; I Barrow; K Beeson; D Busam; A Carver; A Center; M L Cheng; L Curry; S Danaher; L Davenport; R Desilets; S Dietz; K Dodson; L Doup; S Ferriera; N Garg; A Gluecksmann; B Hart; J Haynes; C Haynes; C Heiner; S Hladun; D Hostin; J Houck; T Howland; C Ibegwam; J Johnson; F Kalush; L Kline; S Koduru; A Love; F Mann; D May; S McCawley; T McIntosh; I McMullen; M Moy; L Moy; B Murphy; K Nelson; C Pfannkoch; E Pratts; V Puri; H Qureshi; M Reardon; R Rodriguez; Y H Rogers; D Romblad; B Ruhfel; R Scott; C Sitter; M Smallwood; E Stewart; R Strong; E Suh; R Thomas; N N Tint; S Tse; C Vech; G Wang; J Wetter; S Williams; M Williams; S Windsor; E Winn-Deen; K Wolfe; J Zaveri; K Zaveri; J F Abril; R Guigó; M J Campbell; K V Sjolander; B Karlak; A Kejariwal; H Mi; B Lazareva; T Hatton; A Narechania; K Diemer; A Muruganujan; N Guo; S Sato; V Bafna; S Istrail; R Lippert; R Schwartz; B Walenz; S Yooseph; D Allen; A Basu; J Baxendale; L Blick; M Caminha; J Carnes-Stine; P Caulk; Y H Chiang; M Coyne; C Dahlke; A Deslattes Mays; M Dombroski; M Donnelly; D Ely; S Esparham; C Fosler; H Gire; S Glanowski; K Glasser; A Glodek; M Gorokhov; K Graham; B Gropman; M Harris; J Heil; S Henderson; J Hoover; D Jennings; C Jordan; J Jordan; J Kasha; L Kagan; C Kraft; A Levitsky; M Lewis; X Liu; J Lopez; D Ma; W Majoros; J McDaniel; S Murphy; M Newman; T Nguyen; N Nguyen; M Nodell; S Pan; J Peck; M Peterson; W Rowe; R Sanders; J Scott; M Simpson; T Smith; A Sprague; T Stockwell; R Turner; E Venter; M Wang; M Wen; D Wu; M Wu; A Xia; A Zandieh; X Zhu
Journal:  Science       Date:  2001-02-16       Impact factor: 47.728

Review 10.  Exserohilum: an emerging human pathogen.

Authors:  A Adler; I Yaniv; Z Samra; J Yacobovich; S Fisher; G Avrahami; I Levy
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-04       Impact factor: 5.103

View more
  28 in total

1.  Efficacy and Pharmacokinetics of Fosmanogepix (APX001) in the Treatment of Candida Endophthalmitis and Hematogenous Meningoencephalitis in Nonneutropenic Rabbits.

Authors:  Ruta Petraitiene; Vidmantas Petraitis; Bo Bo Win Maung; Robert S Mansbach; Michael R Hodges; Malcolm A Finkelman; Karen Joy Shaw; Thomas J Walsh
Journal:  Antimicrob Agents Chemother       Date:  2021-02-17       Impact factor: 5.191

2.  Whole-genome analysis of Exserohilum rostratum from an outbreak of fungal meningitis and other infections.

Authors:  Anastasia P Litvintseva; Steven Hurst; Lalitha Gade; Michael A Frace; Remy Hilsabeck; James M Schupp; John D Gillece; Chandler Roe; David Smith; Paul Keim; Shawn R Lockhart; Shankar Changayil; M Ryan Weil; Duncan R MacCannell; Mary E Brandt; David M Engelthaler
Journal:  J Clin Microbiol       Date:  2014-06-20       Impact factor: 5.948

Review 3.  Chronic Meningitis.

Authors:  Kiran T Thakur; Michael R Wilson
Journal:  Continuum (Minneap Minn)       Date:  2018-10

Review 4.  Updates in Laboratory Diagnostics for Invasive Fungal Infections.

Authors:  David Terrero-Salcedo; Margaret V Powers-Fletcher
Journal:  J Clin Microbiol       Date:  2020-05-26       Impact factor: 5.948

5.  Questionable utility of galactomannan testing for diagnosis of Exserohilum rostratum infection.

Authors:  Nuntra Suwantarat; Richard Lee; Karen C Carroll; Sean X Zhang
Journal:  J Clin Microbiol       Date:  2014-07       Impact factor: 5.948

6.  Update on fungal diagnostics.

Authors:  Allen T Griffin; Kimberly E Hanson
Journal:  Curr Infect Dis Rep       Date:  2014-08       Impact factor: 3.725

Review 7.  Methods of rapid diagnosis for the etiology of meningitis in adults.

Authors:  Nathan C Bahr; David R Boulware
Journal:  Biomark Med       Date:  2014       Impact factor: 2.851

8.  The diagnostic performance of the beta-glucan assay in the detection of intra-amniotic infection with Candida species.

Authors:  Percy Pacora; Roberto Romero; Offer Erez; Eli Maymon; Bogdan Panaitescu; Juan Pedro Kusanovic; Adi L Tarca; Chaur-Dong Hsu; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2017-12-27

9.  Detection of (1,3)-β-d-Glucan in Cerebrospinal Fluid in Histoplasma Meningitis.

Authors:  Thein Myint; Felicia C Chow; Karen C Bloch; Luke Raymond-Guillen; Thomas E Davis; Patty W Wright; Laila Woc-Colburn; Raed N Khairy; Alan C Street; Tomotaka Yamamoto; Amanda Albers; L Joseph Wheat; Chadi A Hage
Journal:  J Clin Microbiol       Date:  2018-09-25       Impact factor: 5.948

10.  (1→3)-β-d-Glucan in Cerebrospinal Fluid as a Biomarker for Candida and Aspergillus Infections of the Central Nervous System in Pediatric Patients.

Authors:  Christine M Salvatore; Tempe K Chen; Sima S Toussi; Patricia DeLaMora; Ruta Petraitiene; Malcolm A Finkelman; Thomas J Walsh
Journal:  J Pediatric Infect Dis Soc       Date:  2015-03-19       Impact factor: 3.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.